InvestorsHub Logo
Followers 155
Posts 2642
Boards Moderated 0
Alias Born 01/29/2004

Re: Hoskuld post# 440938

Thursday, 11/30/2023 8:50:30 AM

Thursday, November 30, 2023 8:50:30 AM

Post# of 462165
Wait! The Real Reason Dr. Kellerman Signed On.

It will be a lot of fun for someone who cares about this kind of work to actually have a basketful of meaningful submissions to try to compile, perfect, submit, and support/defend.


Well, that sure makes sense, doesn't it?

But only if Dr. Kellerman, now at Anavex, has positive clinical data that she can actually "compile, perfect, submit, and support/defend."

What can she "submit," "support," or "defend" if the p-values from the blarcamesine clinical studies on humans are simply too weak for regulatory approval anywhere in the world?

Maybe Dr. Kellerman is a quiet, behind the scenes Anavex critic, and has surreptitiously taken this new position, like the critics here, to finally and definitely prove, with drug approval submissions that will surely be rejected, that all of the Anavex science, such as it so weakly is, should be tossed; thereby saving ignorant but hopeful equity investors lots of otherwise lost dollars. What a saint this Dr. Kellerman will turn out to be.

Who could 'a thought?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News